Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma

Jianbiao Zhou(National University Cancer Institute, Singapore), Wee Joo Chng(National University Health System)

Molecular Cancer

April 10, 2023

10.1186/s12943-023-01767-1

Cited by 36

Related Papers

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML

|Blood|2011|212

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

|Blood|2006|182

Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia

|Journal of Hematology & Oncology|2017|75

PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy

|PLoS ONE|2011|65

PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms

|Oncotarget|2015|50